Patients most likely to benefit from GLP-1 therapy for fat reduction include those with a BMI of 30 kg/m or greater, or a BMI of 27 kg/m or greater with weight-related conditions such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease
I usually place copper peptides high on the shortlist for pale, established marks that need a more treatment-led formula
doi: 10.1056/NEJM199809173391202 [PubMed] 20878265 Rossetti AO, Milligan TA, Vullimoz S, Michaelides C, Bertschi M, Lee JW
We build a program around your body not a one-size template
The use of "GLP-1" terminology in supplement marketing reflects conceptual positioning and does not indicate FDA approval, physiological equivalence, or interaction with prescription GLP-1 medications
More from APLB